KNWN - Know Labs, Inc.

Other OTC - Other OTC Delayed Price. Currency in USD
4.48
+0.33 (+7.95%)
At close: 3:59PM EDT
Stock chart is not supported by your current browser
Previous Close4.15
Open0.00
Bid0.00 x 0
Ask0.00 x 0
Day's Range0.00 - 0.00
52 Week Range
Volume0
Avg. Volume19,041
Market Cap74.791M
Beta (3Y Monthly)1.97
PE Ratio (TTM)N/A
EPS (TTM)-0.56
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • Business Wire7 days ago

    Know Labs Announces Bio-RFID™ Product Platform

    Know Labs, Inc. (KNWN) – a provider of diagnostic solutions, released today a video highlighting the Company’s product pathway and platform. In the video CEO Phil Bosua discusses the Company’s Bio-RFID™ technological breakthrough and the plans for bringing the technology to market.

  • James Anderson, MD, Joins Know Labs as Medical Director
    Business Wirelast month

    James Anderson, MD, Joins Know Labs as Medical Director

    Know Labs, Inc. (KNWN) – the developer of the calorie counter UBAND™ wearable and its underlying non-invasive continuous glucose monitoring technology, announced today that James Anderson, MD, has joined the Company as Medical Director. Dr. Anderson will also serve as Chairman of the Company’s Medical, Scientific and Regulatory Affairs Advisory Board. Phil Bosua, Know Labs CEO, stated, “Dr. Anderson immediately understood the science underlying our technology, and shares our vision for its application to medical diagnostics and therapeutics.

  • Know Labs Announces UBAND™ Calorie Counter Wristband
    Business Wire2 months ago

    Know Labs Announces UBAND™ Calorie Counter Wristband

    Know Labs, Inc. (KNWN) – a provider of identification, authentication and diagnostic solutions, published an advertisement in the Seattle Times newspaper today announcing its UBAND™ real time wearable calorie counter wrist band. The Calorie Counter UBAND is built upon the Company’s recent invention that detects blood glucose non-invasively. Know Labs, Inc. (f/k/a Visualant Incorporated) is a public company whose shares currently trade under the stock symbol “KNWN.” The company’s technology directs structured light or radio waves through a substance or material to capture a unique molecular signature.

  • Business Wire2 months ago

    Know Labs Announces Laboratory Comparison Tests of its Non-Invasive Blood Glucose Technology and the DexCom G5®

    Know Labs, Inc. (KNWN) – a provider of identification, authentication and diagnostic solutions, released today a video overview of comparison tests of the Company’s invention of a new way to detect blood glucose non-invasively and the DexCom G5®. In the video, Company CEO Phil Bosua discusses the breakthrough and highlights a comparison of the Know Labs Bio-RFID™ technology with an industry leading continuous glucose monitor from DexCom, Inc. (DXCM). “We’ve just invented a holy grail of the bio-tech industry – non-invasive – blood glucose monitoring.

  • Business Wire3 months ago

    Know Labs Invents New Way to Detect Blood Glucose - Non-invasively

    Know Labs, Inc. (f/k/a Visualant, Incorporated) (KNWN) – a provider of identification, authentication and diagnostic solutions, released today a video of the Company’s invention of a new technology to detect blood glucose non-invasively. In the video, Company CEO Phil Bosua briefly discusses the breakthrough. “We’re developing a brand-new technology platform that measures blood glucose - non-invasively.

  • Business Wire5 months ago

    Know Labs Appoints Michael Grabham Chief Business Officer

    Know Labs, Inc. (f/k/a Visualant, Incorporated) (KNWN) – a provider of identification, authentication and diagnostic solutions, announced today that Michael Grabham has been appointed Chief Business Officer of the Company. Michael Grabham is a Seattle serial entrepreneur who has started six companies over the past 25 years. Grabham has led, as President, several companies from a regional telecommunications company ($14M annual sales) to a software assessment company (startup).